Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Oncopeptides AB | 410,696 | net | 16 Mar 2026 | tx 8+481,396−70,700 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 16 Mar 2026 | PURCHASE | Oncopeptides AB | 140,232 | 1.55 SEK | first after silence |
| 03 May 2024 | PURCHASE | Oncopeptides AB | 160,264 | 2.60 SEK | first after silence |
| 20 Nov 2020 | PURCHASE | Oncopeptides AB | 29,700 | 0.11 SEK | first after silence |
| 23 Nov 2020 | SALE | Oncopeptides AB | 29,700 | 161.97 SEK | |
| 24 Sept 2019 | SALE | Oncopeptides AB | 30,000 | 124.80 SEK | |
| 25 Sept 2018 | SALE | Oncopeptides AB | 5,000 | 160.36 SEK | |
| 24 Sept 2018 | SALE | Oncopeptides AB | 6,000 | 160.00 SEK | |
| 02 Aug 2018 | PURCHASE | Oncopeptides AB | 151,200 | 0.11 SEK |
3 purchases reported after at least 12 months of silence — most recent on 16 Mar 2026.